pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-23a |
Genomic Coordinates | chr19: 13836587 - 13836659 |
Synonyms | MIRN23A, hsa-mir-23a, miRNA23A, MIR23A |
Description | Homo sapiens miR-23a stem-loop |
Comment | This miRNA was previously named miR-23 . This finding was later retracted after the discovery that the regulated gene was human homolog of ES1 (HES1), whose function is unknown. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-23a-5p | |||||||||
Sequence | 9| GGGGUUCCUGGGGAUGGGAUUU |30 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Cloned | |||||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | HDGF | ||||||||||||||||||||
Synonyms | HMG1L2 | ||||||||||||||||||||
Description | heparin binding growth factor | ||||||||||||||||||||
Transcript | NM_001126050 | ||||||||||||||||||||
Other Transcripts | NM_001126051 , NM_004494 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on HDGF | |||||||||||||||||||||
3'UTR of HDGF (miRNA target sites are highlighted) |
>HDGF|NM_001126050|3'UTR 1 CCACCAATGTTTCAAGAGGAGCCCCCACCCTGTTCCTGCTGCTGTCTGGGTGCTACTGGGGAAACTGGCCATGGCCTGCA 81 AACTGGGAACCCCTTTCCCACCCCAACCTGCTCTCCTCTTCTACTCACTTTTCCCACTCCAAGCCCAGCCCATGGAGATT 161 GACCTGGATGGGGCAGGCCACCTGGCTCTCACCTCTAGGTCCCCATACTCCTATGATCTGAGTCAGAGCCATGTCTTCTC 241 CCTGGAATGAGTTGAGGCCACTGTGTTCCTTCCGCTTGGAGCTATTTTCCAGGCTTCTGCTGGGGCCTGGGACAACTGCT 321 CCCACCTCCTGACACCCTTCTCCCACTCTCCTAGGCATTCTGGACCTCTGGGTTGGGATCAGGGGTAGGAATGGAAAGGA 401 TGGAGCATCAACAGCAGGGTGGGCTTGTGGGGCCTGGGAGGGGCAATCCTCAAATGCGGGGTGGGGGCAGCACAGGAGGG 481 CGGCCTCCTTCTGAGCTCCTGTCCCCTGCTACACCTATTATCCCAGCTGCCTAGATTCAGGGAAAGTGGGACAGCTTGTA 561 GGGGAGGGGCTCCTTTCCATAAATCCTTGATGATTGACAACACCCATTTTTCCTTTTGCCGACCCCAAGAGTTTTGGGAG 641 TTGTAGTTAATCATCAAGAGAATTTGGGGCTTCCAAGTTGTTCGGGCCAAGGACCTGAGACCTGAAGGGTTGACTTTACC 721 CATTTGGGTGGGAGTGTTGAGCATCTGTCCCCCTTTAGATCTCTGAAGCCACAAATAGGATGCTTGGGAAGACTCCTAGC 801 TGTCCTTTTTCCTCTCCACACAGTGCTCAAGGCCAGCTTATAGTCATATATATCACCCAGACATAAAGGAAAAGACACAT 881 TTTTTAGGAAATGTTTTTAATAAAAGAAAATTACAAAAAAAAATTTTAAAGACCCCTAACCCTTTGTGTGCTCTCCATTC 961 TGCTCCTTCCCCATCGTTGCCCCCATTTCTGAGGTGCACTGGGAGGCTCCCCTTCTATTTGGGGCTTGATGACTTTCTTT 1041 TTGTAGCTGGGGCTTTGATGTTCCTTCCAGTGTCATTTCTCATCCACATACCCTGACCTGGCCCCCTCAGTGTTGTCACC 1121 AGATCTGATTTGTAACCCACTGAGAGGACAGAGAGAAATAAGTGCCCTCTCCCACCCTCTTCCTACTGGTCTCTCTATGC 1201 CTCTCTACAGTCTCGTCTCTTTTACCCTGGCCCCTCTCCCTTGGGCTCTGATGAAAAATTGCTGACTGTAGCTTTGGAAG 1281 TTTAGCTCTGAGAACCGTAGATGATTTCAGTTCTAGGAAAATAAAACCCGTTGATTACTATAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000357325.5 | 3UTR | AACCCCUUUCCCACCCCAACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
131 hsa-miR-23a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038958 | ATF1 | activating transcription factor 1 | 1 | 1 | ||||||||
MIRT057661 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT395438 | NFKBID | NFKB inhibitor delta | 2 | 2 | ||||||||
MIRT463884 | WNT7B | Wnt family member 7B | 2 | 4 | ||||||||
MIRT475804 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT478528 | CTNS | cystinosin, lysosomal cystine transporter | 2 | 2 | ||||||||
MIRT479278 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 6 | ||||||||
MIRT492564 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | 2 | 2 | ||||||||
MIRT500353 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT509788 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 4 | ||||||||
MIRT511566 | HIST3H2BB | histone cluster 3 H2B family member b | 2 | 4 | ||||||||
MIRT525450 | GPATCH2L | G-patch domain containing 2 like | 2 | 2 | ||||||||
MIRT539558 | CNKSR3 | CNKSR family member 3 | 2 | 4 | ||||||||
MIRT540034 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 4 | ||||||||
MIRT540225 | SAMD5 | sterile alpha motif domain containing 5 | 2 | 2 | ||||||||
MIRT540242 | RGS17 | regulator of G protein signaling 17 | 2 | 2 | ||||||||
MIRT540871 | ZBTB24 | zinc finger and BTB domain containing 24 | 2 | 2 | ||||||||
MIRT559065 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 4 | ||||||||
MIRT560685 | HIST1H1T | histone cluster 1 H1 family member t | 2 | 2 | ||||||||
MIRT565593 | SLC35G1 | solute carrier family 35 member G1 | 2 | 2 | ||||||||
MIRT565642 | SKI | SKI proto-oncogene | 2 | 2 | ||||||||
MIRT576747 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT607712 | LIMS1 | LIM zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT615682 | NAV2 | neuron navigator 2 | 2 | 2 | ||||||||
MIRT617337 | ZSCAN2 | zinc finger and SCAN domain containing 2 | 2 | 2 | ||||||||
MIRT617378 | FAM227A | family with sequence similarity 227 member A | 2 | 2 | ||||||||
MIRT620855 | SERPING1 | serpin family G member 1 | 2 | 2 | ||||||||
MIRT625112 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT625124 | NUP93 | nucleoporin 93 | 2 | 2 | ||||||||
MIRT625898 | LINC00632 | long intergenic non-protein coding RNA 632 | 2 | 2 | ||||||||
MIRT626016 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT626481 | ADAT1 | adenosine deaminase, tRNA specific 1 | 2 | 2 | ||||||||
MIRT626573 | MED7 | mediator complex subunit 7 | 2 | 2 | ||||||||
MIRT626814 | PRR11 | proline rich 11 | 2 | 2 | ||||||||
MIRT628136 | HM13 | histocompatibility minor 13 | 2 | 2 | ||||||||
MIRT630771 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | 2 | 2 | ||||||||
MIRT633133 | C6orf132 | chromosome 6 open reading frame 132 | 2 | 2 | ||||||||
MIRT636950 | APTX | aprataxin | 2 | 2 | ||||||||
MIRT637802 | GGPS1 | geranylgeranyl diphosphate synthase 1 | 2 | 2 | ||||||||
MIRT638622 | GSR | glutathione-disulfide reductase | 2 | 4 | ||||||||
MIRT642196 | SMAGP | small cell adhesion glycoprotein | 2 | 2 | ||||||||
MIRT645121 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT645344 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT646564 | ALDH5A1 | aldehyde dehydrogenase 5 family member A1 | 2 | 2 | ||||||||
MIRT649243 | TRIM65 | tripartite motif containing 65 | 2 | 2 | ||||||||
MIRT651810 | USP49 | ubiquitin specific peptidase 49 | 2 | 2 | ||||||||
MIRT652137 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | 2 | 2 | ||||||||
MIRT652668 | TIMELESS | timeless circadian clock | 2 | 2 | ||||||||
MIRT655894 | NEK9 | NIMA related kinase 9 | 2 | 2 | ||||||||
MIRT656564 | LYRM7 | LYR motif containing 7 | 2 | 2 | ||||||||
MIRT657194 | IKZF3 | IKAROS family zinc finger 3 | 2 | 2 | ||||||||
MIRT657907 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT660207 | BMPR1A | bone morphogenetic protein receptor type 1A | 2 | 2 | ||||||||
MIRT660619 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT660826 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT660986 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT662232 | PGBD4 | piggyBac transposable element derived 4 | 2 | 2 | ||||||||
MIRT663691 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT665577 | TUBD1 | tubulin delta 1 | 2 | 2 | ||||||||
MIRT666149 | SP2 | Sp2 transcription factor | 2 | 2 | ||||||||
MIRT666310 | SLC22A3 | solute carrier family 22 member 3 | 2 | 2 | ||||||||
MIRT666457 | SCRG1 | stimulator of chondrogenesis 1 | 2 | 2 | ||||||||
MIRT667716 | KIAA1468 | KIAA1468 | 2 | 2 | ||||||||
MIRT668329 | FKBP5 | FK506 binding protein 5 | 2 | 2 | ||||||||
MIRT668370 | FBXO47 | F-box protein 47 | 2 | 2 | ||||||||
MIRT669304 | C17orf75 | chromosome 17 open reading frame 75 | 2 | 2 | ||||||||
MIRT669538 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | 2 | 2 | ||||||||
MIRT671681 | ADK | adenosine kinase | 2 | 2 | ||||||||
MIRT672177 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 2 | ||||||||
MIRT673604 | HPSE | heparanase | 2 | 2 | ||||||||
MIRT673749 | ZNF333 | zinc finger protein 333 | 2 | 2 | ||||||||
MIRT674807 | FAM229B | family with sequence similarity 229 member B | 2 | 2 | ||||||||
MIRT675286 | ARL10 | ADP ribosylation factor like GTPase 10 | 2 | 2 | ||||||||
MIRT675391 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT675788 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT676151 | OGFOD1 | 2-oxoglutarate and iron dependent oxygenase domain containing 1 | 2 | 2 | ||||||||
MIRT676499 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT676621 | CSNK1E | casein kinase 1 epsilon | 2 | 2 | ||||||||
MIRT676644 | GTDC1 | glycosyltransferase like domain containing 1 | 2 | 2 | ||||||||
MIRT676711 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT676809 | SHROOM4 | shroom family member 4 | 2 | 2 | ||||||||
MIRT677036 | FOXO3 | forkhead box O3 | 2 | 2 | ||||||||
MIRT677062 | NT5C2 | 5'-nucleotidase, cytosolic II | 2 | 2 | ||||||||
MIRT677086 | SMIM15 | small integral membrane protein 15 | 2 | 2 | ||||||||
MIRT677193 | MURC | caveolae associated protein 4 | 2 | 2 | ||||||||
MIRT677273 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT677345 | POC1A | POC1 centriolar protein A | 2 | 2 | ||||||||
MIRT677504 | SLC10A6 | solute carrier family 10 member 6 | 2 | 2 | ||||||||
MIRT677526 | OCIAD2 | OCIA domain containing 2 | 2 | 2 | ||||||||
MIRT677661 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 2 | ||||||||
MIRT677727 | SSR1 | signal sequence receptor subunit 1 | 2 | 2 | ||||||||
MIRT677803 | PNPLA3 | patatin like phospholipase domain containing 3 | 2 | 2 | ||||||||
MIRT678144 | SLC4A4 | solute carrier family 4 member 4 | 2 | 2 | ||||||||
MIRT678376 | VTA1 | vesicle trafficking 1 | 2 | 2 | ||||||||
MIRT678708 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 2 | 2 | ||||||||
MIRT678868 | FAM118A | family with sequence similarity 118 member A | 2 | 2 | ||||||||
MIRT679039 | LACTB | lactamase beta | 2 | 2 | ||||||||
MIRT679081 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT679137 | SYK | spleen associated tyrosine kinase | 2 | 2 | ||||||||
MIRT679299 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT679741 | CABP4 | calcium binding protein 4 | 2 | 2 | ||||||||
MIRT679946 | AS3MT | arsenite methyltransferase | 2 | 2 | ||||||||
MIRT679976 | E2F2 | E2F transcription factor 2 | 2 | 2 | ||||||||
MIRT683628 | MTO1 | mitochondrial tRNA translation optimization 1 | 2 | 2 | ||||||||
MIRT683901 | PSMB9 | proteasome subunit beta 9 | 2 | 2 | ||||||||
MIRT684172 | MOG | myelin oligodendrocyte glycoprotein | 2 | 2 | ||||||||
MIRT684231 | C20orf144 | chromosome 20 open reading frame 144 | 2 | 2 | ||||||||
MIRT685403 | C1orf158 | chromosome 1 open reading frame 158 | 2 | 2 | ||||||||
MIRT686253 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT687513 | NCKAP1 | NCK associated protein 1 | 2 | 2 | ||||||||
MIRT688243 | FITM2 | fat storage inducing transmembrane protein 2 | 2 | 2 | ||||||||
MIRT688315 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT688733 | CNDP1 | carnosine dipeptidase 1 | 2 | 2 | ||||||||
MIRT689031 | ANGPTL3 | angiopoietin like 3 | 2 | 2 | ||||||||
MIRT698207 | TMEM248 | transmembrane protein 248 | 2 | 2 | ||||||||
MIRT699859 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT709954 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT711541 | MSH3 | mutS homolog 3 | 2 | 2 | ||||||||
MIRT712077 | WDR37 | WD repeat domain 37 | 2 | 2 | ||||||||
MIRT715312 | POLR2E | RNA polymerase II subunit E | 2 | 2 | ||||||||
MIRT715725 | PIAS2 | protein inhibitor of activated STAT 2 | 2 | 2 | ||||||||
MIRT715748 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | 2 | 2 | ||||||||
MIRT717604 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT717875 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT718042 | NIPAL2 | NIPA like domain containing 2 | 2 | 2 | ||||||||
MIRT718829 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT724037 | CAMK2N2 | calcium/calmodulin dependent protein kinase II inhibitor 2 | 2 | 2 | ||||||||
MIRT733305 | TNF | tumor necrosis factor | 1 | 0 | ||||||||
MIRT734941 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 3 | 0 | ||||||||
MIRT737343 | IGF2 | insulin like growth factor 2 | 3 | 0 | ||||||||
MIRT737546 | PTEN | phosphatase and tensin homolog | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|